1. Neurovascular/Interventional Neurology Market [Aneurysm
Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid
Embolic Agents, & Cerebral Angioplasty Balloons] - Global
Trends & Competitive Analysis to 2017
Report Details:
Published:October 2012
No. of Pages: 234
Price: Single User License – US$4650
Neurointerventional radiology or endovascular neurosurgery refers to special minimally invasive
procedures to diagnose and treat vascular disorders of the brain and spine. With the help of
advanced imaging for guidance, neurointerventionalists or neurosurgeons use microcatheters (tiny
tubes) to treat many complex disorders. Normally these disorders are treated either by closing
(embolization) or opening (recanalization) the abnormal vessels. The neurointerventional device
market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and
snare device), cerebral angiography and stenting system (carotid stent, and embolic protection
system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device)
and support devices (microcatheter, and microguidewire).
The neurointerventional devices market encompasses neurothrombectomy devices
(suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting
system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil,
liquid embolic agents, and flow diversion device) and support devices (microcatheter, and
microguidewire).
The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and is
expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling &
Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest
share of the global neurointerventional devices market, followed by support devices cerebral
balloon angioplasty & stenting systems and neurothrombectomy devices in 2012.
The major driving factor for these markets involves gradual technological evolution, growing
ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and
increasing demand for minimally invasive surgical procedures. Growing GDP and healthcare
allocation are making developing countries in Asia and Latin America affordable to adapt novel
2. medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring
the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage
to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum
surgical trauma and lesser surgical scar.
North America dominates the overall neurointerventional devices market. Asia-Pacific market
including India, China and Japan, and Latin America market are expected to grow at a higher pace
due to the effect of growing GDP and purchasing capability of healthcare institutions in those
countries. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific and
Latin American market.
The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.),
Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).
Scope of the Report
This research report categorizes the neurointerventional device market for devices used in
neurothrombectomy procedure, cerebral angiography and stenting technique, aneurysm coiling
procedure and support devices.
Various neurointerventional devices are categorized into:
•Neurothrombectomy procedure - Suction/aspiration device, clot retriever, and snare device
•Cerebral angiography and stenting technique - Carotid stent, and embolic protection system
•Aneurysm coiling procedure – Platinum coil (Bare & Coated), Liquid embolic agents, and Flow
diversion device.
•Support devices - Microcatheter and Microguidewire
Get your copy of this report @
http://www.reportsnreports.com/reports/203750-neurovascular-interventional-neurology-market-aneurysm-coils-
carotid-stents-microcatheter-microguidewire-liquid-embolic-agents-cerebral-angioplasty-balloons-global-trends-
competitive-analysis-to-2017.html
Major points covered in Table of Contents of this report include
Table Of Contents
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
3. 1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Advancements in technology
3.3.1.2 Increasing aging & obese population
3.3.1.3 Increasing number of ischemic & hemorrhagic stroke patients
3.3.1.4 Growing demand for minimally invasive surgery
3.3.2 RESTRAINTS
3.3.2.1 Increasing complexity in clinical trials
3.3.2.2 Decreasing average selling prices
3.3.2.3 Hospital budget constraints& alternative treatment facilities
3.3.3 THREATS & OPPORTUNITIES
3.4 TRENDS
3.5 UPCOMING TECHNOLOGIES
3.6 MARKET SHARE ANALYSIS
4 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY TECHNIQUES
4.1 INTRODUCTION
4.2 NEUROTHROMBECTOMY
4.3 CAROTID ARTERY ANGIOGRAPHY & STENTING
4.4 EMBOLIZATION OF ARTERIOVENOUS MALFORMATION ARTERIOVENOUS FISTULA
4.5 COILING PROCEDURE
5 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCTS
5.1 NEUROTHROMBECTOMY DEVICES
5.1.1 INTRODUCTION
5.1.2 SUCTION/ASPIRATION DEVICES
5.1.3 CLOT RETRIEVER
5.1.4 SNARE
5.2 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS
5.2.1 INTRODUCTION
5.2.2 CAROTID ARTERY STENTS
5.2.3 EMBOLIC PROTECTION SYSTEMS
5.2.3.1 Distal filter devices
5.2.3.2 Balloon occlusion devices
4. 5.3 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA
EMBOLIZATION
5.3.1 INTRODUCTION
5.3.2 EMBOLIC COIL
5.3.2.1 Bare Platinum Detachable Coil
5.3.2.2 Coated Detachable Coil
5.3.3 LIQUID EMBOLIC AGENTS
5.3.4 FLOW DIVERSION DEVICE
5.4 SUPPORT DEVICES
5.4.1 INTRODUCTION
5.4.2 MICROCATHETER
5.4.3 MICROGUIDEWIRE
6 GEOGRAPHIC ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA
6.5 REST OF THE WORLD (ROW)
7 COMPETITIVE LANDSCAPE
7.1 MERGERS & ACQUISITIONS
7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
7.3 NEW PRODUCT LAUNCH
7.4 APPROVAL
7.5 EXPANSION
7.6 OTHER DEVELOPMENTS
8 COMPANY PROFILES
8.1 ABBOTT LABORATORIES
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCTS & SERVICES
8.1.4 STRATEGY
8.1.5 DEVELOPMENTS
8.2 BAYER AG
8.2.1 OVERVIEW
8.2.2 FINANCIAL
8.2.3 PRODUCTS & SERVICES
8.2.4 STRATEGY
8.2.5 DEVELOPMENTS
8.3 COAXIA, INC.